Back to search
FDAFDA · Food and drugs·Recall number D-0053-2018

ENALAPRIL MALEATE Tablets, USP, 5MG, 90-count bottles, Rx only, MFG: Wockhardt Ltd., India; Packaged By: Aidarex Pharmaceuticals; NDC 33261-0693-90.

Published November 1, 2017 · Recall initiated: September 5, 2017

Summary

FDA records drug Class III recall D-0053-2018, published November 1, 2017 and initiated September 5, 2017. Recalling firm: Aidarex Pharmaceuticals LLC; Status: Terminated; Reported quantity: 12 bottles; Lot: Lot #: 55097-2, 56085-1, Exp 11/30/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aidarex Pharmaceuticals LLC
Distributor
Product was distributed in Florida
Lot
Lot #: 55097-2, 56085-1, Exp 11/30/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ENALAPRIL MALEATE Tablets, USP, 5MG, 90-count bottles, Rx only, MFG: Wockhardt Ltd., India; Packaged By: Aidarex Pharmaceuticals; NDC 33261-0693-90. recalled?

Yes. FDA published recall D-0053-2018 on November 1, 2017. Reported hazard: Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail